Skip to main content

Advertisement

ADVERTISEMENT

Volume 17 - Issue 8 - August, 2005

Feature

Vascular Disease
08/01/2008
Akio Kawamura, MD, Thomas C. Piemonte, MD, Richard W. Nesto, MD, Seth D. Bilazarian, MD, Nabila S. Riskalla, RN, Manish S. Chauhan, MD
Akio Kawamura, MD, Thomas C. Piemont...
Women with coronary artery disease (CAD) are known to have a higher prevalence of co-morbidities than men, including advanced age, hypertension, diabetes and concomitant non-cardiac disease. Female gender has been shown to be an independent...
Women with coronary artery disease (CAD) are known to have a higher prevalence of co-morbidities than men, including advanced age, hypertension, diabetes and concomitant non-cardiac disease. Female gender has been shown to be an independent...
Women with coronary artery...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
08/01/2008
David G. Rizik, MD, Denise A. Dowler, MSN, NP, Bernard J. Villegas, MD
David G. Rizik, MD, Denise A. Dowler...
Case Presentation. A 65-year-old gentleman, who works as a professional football referee, presented with progressive symptoms of angina. His job officiating games necessitated significant physical activity and endurance. He presented 10 days...
Case Presentation. A 65-year-old gentleman, who works as a professional football referee, presented with progressive symptoms of angina. His job officiating games necessitated significant physical activity and endurance. He presented 10 days...
Case Presentation. A 65-year-old...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Chi Hang Lee, MD, Poo Sing Wong, MD, Huay Cheem Tan, MD, Yean Teng Lim, MD
Chi Hang Lee, MD, Poo Sing Wong, MD,...
The X-Sizer® (ev3, Inc., Plymouth, Minnesota) is a novel thrombectomy device that effectively removes intracoronary thrombus. Recent studies suggest that pre-treatment with the X-Sizer before percutaneous coronary intervention (PCI) in a...
The X-Sizer® (ev3, Inc., Plymouth, Minnesota) is a novel thrombectomy device that effectively removes intracoronary thrombus. Recent studies suggest that pre-treatment with the X-Sizer before percutaneous coronary intervention (PCI) in a...
The X-Sizer® (ev3, Inc.,...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Wai-Hong Chen, MBBS, Pui-Yin Lee, MBBS, Elaine P Wang, MD*
Wai-Hong Chen, MBBS, Pui-Yin Lee, MB...
Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI). The incidence is 0.1% with lesions treated by balloon angioplasty and 0.5–3.0% with lesions treated by atheroablative devices.1 It can...
Coronary artery perforation is a rare but serious complication of percutaneous coronary intervention (PCI). The incidence is 0.1% with lesions treated by balloon angioplasty and 0.5–3.0% with lesions treated by atheroablative devices.1 It can...
Coronary artery perforation is a...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Enio E. Guérios, MD, PhD, Ronaldo Bueno, MD, PhD, Deborah Nercolini, MD, José Tarastchuk, MD, Paulo Andrade, MD, Alvaro Pacheco, MD, Alysson Faidiga, MD, Stefan Negrao, MD*, Antonio Barbosa, MD*
Enio E. Guérios, MD, PhD, Ronaldo B...
Several studies have determined the safety and efficacy of percutaneous mitral valvuloplasty (PMV) during pregnancy, the larger series being those recently described by Esteves,122 Nercolini et al.,118 and Ben Farhat et al.120 Retrospectively...
Several studies have determined the safety and efficacy of percutaneous mitral valvuloplasty (PMV) during pregnancy, the larger series being those recently described by Esteves,122 Nercolini et al.,118 and Ben Farhat et al.120 Retrospectively...
Several studies have determined...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Speaker: Fayaz Shawl, MD Moderator: Barry George, MD Panelists: Jiri Vitek, MD, Michael Mooney, MD, Christopher Cates, MD, Norberto Schechtmann, MD, Renato DeRita (Centocor)
Speaker: Fayaz Shawl, MD Moderator: B...
Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...
Barry George: Needless to say, Fayaz, you have a bias against distal protection, and it’s an emotional issue for those of us who do carotid stenting. Fayaz Shawl: I am not biased, I just think a randomized trial is needed. Barry George: I...
Barry George: Needless to say,...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
David E. Allie, MD, Chris J. Hebert, MD, Mitchell D. Lirtzman, MD, Charles H. Wyatt, MD, V. Antoine Keller, MD, Mohamed H. Khan, MD, Muhammad A. Khan, MD, Peter S. Fail, MD, Krishnamoorthy Vivekananthan, MD, Sonja E. Allie, MD, Elena V. Mitran, MD, Gary Chaisson, MD, Samuel J. Stagg, III, MD, Adam A. Allie, MD, Michael W. McElderry, MD, Esmond A. Barker, MD, Craig M. Walker, MD
David E. Allie, MD, Chris J. Hebert,...
It is estimated that as many as 20% of Americans ? 65 years old and 50% ? 75 years old have peripheral arterial disease (PAD), a total approaching 14–16 million Americans.1-4 With our rapidly increasing elderly population, it is likely that...
It is estimated that as many as 20% of Americans ? 65 years old and 50% ? 75 years old have peripheral arterial disease (PAD), a total approaching 14–16 million Americans.1-4 With our rapidly increasing elderly population, it is likely that...
It is estimated that as many as...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Hannah M. Timlin, BSc, Sarah A. Carnaffin, RGN, Ian R. Starkey, MB, ChB, FRCP, David B. Northridge, MB, FRCP, Stephen J. Leslie, BSc, MB, ChB, MRCP, PhD
Hannah M. Timlin, BSc, Sarah A. Carn...
Percutaneous coronary intervention (PCI) is central to the management of patients with coronary artery disease. Vascular access is most commonly achieved via the femoral artery by inserting a vascular access sheath. To reduce the risk of...
Percutaneous coronary intervention (PCI) is central to the management of patients with coronary artery disease. Vascular access is most commonly achieved via the femoral artery by inserting a vascular access sheath. To reduce the risk of...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Gastón A. Rodriguez-Granillo, MD, Marco Valgimigli, MD, Héctor M. Garcia-Garcia, MD, Andrew T.L. Ong, MD, Jiro Aoki, MD, Carlos A.G. van Mieghem, MD, Keiichi Tsuchida, MD, Georgios Sianos, MD, Eugene McFadden, MD, Willem J. van der Giessen, MD, Ron van Domburg, MD, Pim de Feyter, MD, Patrick W. Serruys, MD
Gastón A. Rodriguez-Granillo, MD, M...
Coronary stenting has significantly improved the angiographic and clinical outcomes in vessels with a reference diameter (RD) > 3 mm.1–5 However, several randomized trials have shown conflicting results when comparing coronary stenting...
Coronary stenting has significantly improved the angiographic and clinical outcomes in vessels with a reference diameter (RD) > 3 mm.1–5 However, several randomized trials have shown conflicting results when comparing coronary stenting...
Coronary stenting has...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Ariel Roguin, MD and Ehud Grenadier, MD
Ariel Roguin, MD and Ehud Grenadier, ...
Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...
Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...
Stent placement in coronary...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement